Clinical Trial Update: A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating eribulin in combination with gemcitabine for advanced liposarcoma or leiomyosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Eribulin (eribulin mesilate)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Yonsei University | Conditions: Sarcoma | Phase 2 | Status: COMPLETED